Kaya

Kaya EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Kaya (KAYA.NS) as of Nov 4, 2026 is -6.76. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -151.03 — a change of -95.53% (higher).

EV/EBIT

-6.76

YoY

-95.53%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Kaya is 2026 -6.76 . EV/EBIT (Enterprise Value to EBIT) of Kaya was 2025 -151.03 . It decreases by -95.53% higher compared to the previous year.

The Kaya EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
-22.22 INR
Jan 1, 2020
-33.35 INR
Jan 1, 2021
-18.10 INR
Jan 1, 2022
-7.82 INR
Jan 1, 2023
-8.88 INR
Jan 1, 2024
-99.14 INR
Jan 1, 2025
-151.03 INR
Jan 1, 2026
-6.76 INR
The Kaya EV/EBIT history
YEAREV/EBITYoY
-6.76-95.53%
-151.03+52.34%
-99.14+1,016.20%
-8.88+13.52%
-7.82-56.77%
-18.10-45.73%
-33.35+50.08%
-22.22+18.45%
-18.76-54.27%
-41.02-187.92%
46.66+255.25%
13.13-89.09%
120.36—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kaya Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Kaya's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Kaya's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Kaya's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Kaya grows earnings faster than its peers.

Kaya Stock analysis

What does Kaya do? Kaya Ltd. generates revenue through its portfolio of health care aesthetics, beauty, and personal care products and services. The company develops specialty products and services in collaboration with its dermatologists, offering solutions for acne, pigmentation, dull skin, and hair concerns. Its product range includes over 80 items such as acne treatments, brightening serums, anti-ageing creams, derma naturals, body care, hair care, and beauty facials. The firm targets consumers seeking professional skin and hair care, particularly those addressing everyday skin and hair needs through its dermatologist-developed offerings. Kaya Ltd. provides a variety of skin and hair-based services, including Oxygeneo Medifacial, Skin and Eye Threads, Profhilo Fillers, Restylane Lyft, Restylane Kysse, and High-intensity focused ultrasound. These services cater to clients looking for advanced aesthetic treatments. The company also offers body care solutions like CoolSculpting Technology, Enzymatic Resurfacing, Venus Legacy, and Happy Intim intimate rejuvenation, appealing to customers focused on body contouring and intimate wellness. Additionally, its skin care services such as IV Boost, DNA Repair Therapy, and Skin Boosters Jalupro target clients seeking specialized skin health solutions. The firm’s revenue streams are derived from both product sales and service offerings, with its dermatologist-developed products and services forming the core of its business model. Kaya Ltd. serves a segment of health-conscious consumers who prioritize professional-grade skin and hair care, leveraging its expertise in dermatology to address specific concerns like acne, pigmentation, and hair issues. The company’s focus on specialty treatments ensures repeat business and customer loyalty within its target market. Kaya is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kaya stock

EV/EBIT (Enterprise Value to EBIT) of Kaya is -6.76 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Kaya changed from -151.03 to -6.76, representing a -95.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Kaya since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Kaya with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Kaya

All Key Metrics — Kaya